Featured News
Fast-Tracking Drug Development with AI-driven Pathology
Announcing our expanded partnership with Deciphex
We are revolutionizing digital pathology to help pharmaceutical and biotech companies accelerate drug development. By integrating Deciphex’s Patholytix platform, we offer seamless image management, enhanced workflow efficiency, and faster, more precise pathology assessments for nonclinical safety studies.
Through our expanded partnership with Deciphex, we are reducing turnaround times, allowing clients to access critical toxicologic pathology insights more quickly. Advanced AI-powered solutions, including Deciphex’s Foresight platform, enhance lesion detection, and support acute toxicity and carcinogenicity studies – ensuring more accurate safety evaluations.
With these innovations, we empower our clients to streamline decision-making, optimize drug development workflows, and bring life-saving therapies to market faster because every moment matters.